Mark Abssy has spent the last 15 years developing indexes and helping new issuers bring thematic ETFs to market including FAN, HACK, SKYY, YYY, IPAY, ISRA, GAMR, CNCR, JGLD, DTOX in the US and ISPY, FOOD, CYBR, DIGI and DTOX in Europe. Over his 30-year career in financial services, he’s held many roles in short-term investments, mutual funds, and CEFs and ETFs at large investment firms like Morgan Stanley, Fidelity Investments, and Loomis Sayles. Abyss is also the founder of All You Can ETF, LLC.
Abssy has been contributing to TheStreet Real Money since 2021. His coverage focuses on thematic investing and ETFs. His experience developing indexes and helping new issuers bring ETFs to market helps him uncover the best ETFs available for his followers.
He received a BSBA from Northeastern University with a focus in Finance and International Business. Outside of work, Abssy can be found coaching rugby or working on his photography skills.
Recent Articles By The Author
Let's compare four crypto-related exchange-traded funds to see which is the best bet for mining profits.
The Invesco S&P Spin-Off exchange-traded fund is holding its own against the SPDR S&P 500 ETF Trust. Can it keep it up?
Let's see how the Invesco Buyback Achievers exchange-traded fund takes a passive approach that can pay off.
This exchange-traded fund focused on Canadian equities has outperformed the SPDR S&P 500 ETF by a nice margin this year.
Let's look at what an ETN is and then get into a type of ETN that has been working for investors so far this year.
It started with asset manager Dimension, and now One Capital Management is aiming Fund X to the exchange-traded fund arena.
Leveraged ETFs are old news but these funds from AXS Investments break new ground.
These exchange-traded funds from Global X offer small investors investment options that once were available only to fat cats.
The Tuttle Capital Short Innovation exchange-traded fund has been outperforming just about everything lately -- here's how and what to consider before you jump aboard.
The AGFiQ U.S. Market Neutral Anti-Beta Fund managed to return 18.50% over the past quarter -- and, no, it's not an inverse or levered inverse fund.